KDM5A and hepatocellular carcinoma: To investigate the functions of KDM5A‐miR‐433 axis in the progression of HCC, we silenced KDM5A and miR‐433 in Hep3B and BEL‐7404 and found that miR‐433 was significantly up‐regulated after KDM5A was silenced and its expression was dramatically reduced after the transfection of the miR‐433 inhibitor (Figure 4A) (P < .05).